Global Carbapenem Drugs Supply, Demand and Key Producers, 2024-2030
The global Carbapenem Drugs market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
Carbapenem antibacterial drugs have a broad antibacterial spectrum and strong antibacterial activity. They have antibacterial effects on both aerobic and anaerobic bacteria, especially on multi-drug resistant Gram-negative bacilli, such as extended-spectrum ?-lactamase-producing ( ESBL) Enterobacteriaceae bacteria have strong antibacterial activity. This type of drug has a wide range of clinical indications and plays an important role in the antibacterial treatment of multi-drug-resistant bacterial infections, mixed infections of aerobic and anaerobic bacteria, severe infections and infections in patients with immunodeficiency.
This report studies the global Carbapenem Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Carbapenem Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Carbapenem Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Carbapenem Drugs total production and demand, 2019-2030, (K Units)
Global Carbapenem Drugs total production value, 2019-2030, (USD Million)
Global Carbapenem Drugs production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Carbapenem Drugs consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Carbapenem Drugs domestic production, consumption, key domestic manufacturers and share
Global Carbapenem Drugs production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Carbapenem Drugs production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Carbapenem Drugs production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).
This reports profiles key players in the global Carbapenem Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Shandong New Era Pharmaceutical, Shenzhen Haibin Pharmaceutical, Sinopharm Guorui Pharmaceutical, Taiwan Biotech Co., Ltd., Merck, Sun Pharmaceutical Industries Ltd., JW Pharmaceutical, Zhengde Pharmaceutical and Hospira Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Carbapenem Drugs market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Carbapenem Drugs Market, By Region:
1. How big is the global Carbapenem Drugs market?
2. What is the demand of the global Carbapenem Drugs market?
3. What is the year over year growth of the global Carbapenem Drugs market?
4. What is the production and production value of the global Carbapenem Drugs market?
5. Who are the key producers in the global Carbapenem Drugs market?
Carbapenem antibacterial drugs have a broad antibacterial spectrum and strong antibacterial activity. They have antibacterial effects on both aerobic and anaerobic bacteria, especially on multi-drug resistant Gram-negative bacilli, such as extended-spectrum ?-lactamase-producing ( ESBL) Enterobacteriaceae bacteria have strong antibacterial activity. This type of drug has a wide range of clinical indications and plays an important role in the antibacterial treatment of multi-drug-resistant bacterial infections, mixed infections of aerobic and anaerobic bacteria, severe infections and infections in patients with immunodeficiency.
This report studies the global Carbapenem Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Carbapenem Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Carbapenem Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Carbapenem Drugs total production and demand, 2019-2030, (K Units)
Global Carbapenem Drugs total production value, 2019-2030, (USD Million)
Global Carbapenem Drugs production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Carbapenem Drugs consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Carbapenem Drugs domestic production, consumption, key domestic manufacturers and share
Global Carbapenem Drugs production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Carbapenem Drugs production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Carbapenem Drugs production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).
This reports profiles key players in the global Carbapenem Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Shandong New Era Pharmaceutical, Shenzhen Haibin Pharmaceutical, Sinopharm Guorui Pharmaceutical, Taiwan Biotech Co., Ltd., Merck, Sun Pharmaceutical Industries Ltd., JW Pharmaceutical, Zhengde Pharmaceutical and Hospira Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Carbapenem Drugs market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Carbapenem Drugs Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Doripenem
- Ertapenem
- Imipenem
- Meropenem
- Panipenem
- Biapenem
- Hospital
- Clinic
- Others
- Shandong New Era Pharmaceutical
- Shenzhen Haibin Pharmaceutical
- Sinopharm Guorui Pharmaceutical
- Taiwan Biotech Co., Ltd.
- Merck
- Sun Pharmaceutical Industries Ltd.
- JW Pharmaceutical
- Zhengde Pharmaceutical
- Hospira Inc.
- WG Critical Care
- Hanhui Pharmaceutical
- Zhuhai United Laboratories
- ACS Dobfar S.p.A
- Iterum Therapeutics plc (ITRM)
- Daewoong Pharmaceutical
- Aurobindo Pharma Ltd
- Sumitomo Pharma
- Pfizer Inc.
1. How big is the global Carbapenem Drugs market?
2. What is the demand of the global Carbapenem Drugs market?
3. What is the year over year growth of the global Carbapenem Drugs market?
4. What is the production and production value of the global Carbapenem Drugs market?
5. Who are the key producers in the global Carbapenem Drugs market?
1 SUPPLY SUMMARY
1.1 Carbapenem Drugs Introduction
1.2 World Carbapenem Drugs Supply & Forecast
1.2.1 World Carbapenem Drugs Production Value (2019 & 2023 & 2030)
1.2.2 World Carbapenem Drugs Production (2019-2030)
1.2.3 World Carbapenem Drugs Pricing Trends (2019-2030)
1.3 World Carbapenem Drugs Production by Region (Based on Production Site)
1.3.1 World Carbapenem Drugs Production Value by Region (2019-2030)
1.3.2 World Carbapenem Drugs Production by Region (2019-2030)
1.3.3 World Carbapenem Drugs Average Price by Region (2019-2030)
1.3.4 North America Carbapenem Drugs Production (2019-2030)
1.3.5 Europe Carbapenem Drugs Production (2019-2030)
1.3.6 China Carbapenem Drugs Production (2019-2030)
1.3.7 Japan Carbapenem Drugs Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Carbapenem Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Carbapenem Drugs Major Market Trends
2 DEMAND SUMMARY
2.1 World Carbapenem Drugs Demand (2019-2030)
2.2 World Carbapenem Drugs Consumption by Region
2.2.1 World Carbapenem Drugs Consumption by Region (2019-2024)
2.2.2 World Carbapenem Drugs Consumption Forecast by Region (2025-2030)
2.3 United States Carbapenem Drugs Consumption (2019-2030)
2.4 China Carbapenem Drugs Consumption (2019-2030)
2.5 Europe Carbapenem Drugs Consumption (2019-2030)
2.6 Japan Carbapenem Drugs Consumption (2019-2030)
2.7 South Korea Carbapenem Drugs Consumption (2019-2030)
2.8 ASEAN Carbapenem Drugs Consumption (2019-2030)
2.9 India Carbapenem Drugs Consumption (2019-2030)
3 WORLD CARBAPENEM DRUGS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Carbapenem Drugs Production Value by Manufacturer (2019-2024)
3.2 World Carbapenem Drugs Production by Manufacturer (2019-2024)
3.3 World Carbapenem Drugs Average Price by Manufacturer (2019-2024)
3.4 Carbapenem Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Carbapenem Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Carbapenem Drugs in 2023
3.5.3 Global Concentration Ratios (CR8) for Carbapenem Drugs in 2023
3.6 Carbapenem Drugs Market: Overall Company Footprint Analysis
3.6.1 Carbapenem Drugs Market: Region Footprint
3.6.2 Carbapenem Drugs Market: Company Product Type Footprint
3.6.3 Carbapenem Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Carbapenem Drugs Production Value Comparison
4.1.1 United States VS China: Carbapenem Drugs Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Carbapenem Drugs Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Carbapenem Drugs Production Comparison
4.2.1 United States VS China: Carbapenem Drugs Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Carbapenem Drugs Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Carbapenem Drugs Consumption Comparison
4.3.1 United States VS China: Carbapenem Drugs Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Carbapenem Drugs Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Carbapenem Drugs Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Carbapenem Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Carbapenem Drugs Production Value (2019-2024)
4.4.3 United States Based Manufacturers Carbapenem Drugs Production (2019-2024)
4.5 China Based Carbapenem Drugs Manufacturers and Market Share
4.5.1 China Based Carbapenem Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Carbapenem Drugs Production Value (2019-2024)
4.5.3 China Based Manufacturers Carbapenem Drugs Production (2019-2024)
4.6 Rest of World Based Carbapenem Drugs Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Carbapenem Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Carbapenem Drugs Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Carbapenem Drugs Production (2019-2024)
5 MARKET ANALYSIS BY TYPE
5.1 World Carbapenem Drugs Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Doripenem
5.2.2 Ertapenem
5.2.3 Imipenem
5.2.4 Meropenem
5.2.5 Panipenem
5.2.6 Biapenem
5.3 Market Segment by Type
5.3.1 World Carbapenem Drugs Production by Type (2019-2030)
5.3.2 World Carbapenem Drugs Production Value by Type (2019-2030)
5.3.3 World Carbapenem Drugs Average Price by Type (2019-2030)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Carbapenem Drugs Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Carbapenem Drugs Production by Application (2019-2030)
6.3.2 World Carbapenem Drugs Production Value by Application (2019-2030)
6.3.3 World Carbapenem Drugs Average Price by Application (2019-2030)
7 COMPANY PROFILES
7.1 Shandong New Era Pharmaceutical
7.1.1 Shandong New Era Pharmaceutical Details
7.1.2 Shandong New Era Pharmaceutical Major Business
7.1.3 Shandong New Era Pharmaceutical Carbapenem Drugs Product and Services
7.1.4 Shandong New Era Pharmaceutical Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Shandong New Era Pharmaceutical Recent Developments/Updates
7.1.6 Shandong New Era Pharmaceutical Competitive Strengths & Weaknesses
7.2 Shenzhen Haibin Pharmaceutical
7.2.1 Shenzhen Haibin Pharmaceutical Details
7.2.2 Shenzhen Haibin Pharmaceutical Major Business
7.2.3 Shenzhen Haibin Pharmaceutical Carbapenem Drugs Product and Services
7.2.4 Shenzhen Haibin Pharmaceutical Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Shenzhen Haibin Pharmaceutical Recent Developments/Updates
7.2.6 Shenzhen Haibin Pharmaceutical Competitive Strengths & Weaknesses
7.3 Sinopharm Guorui Pharmaceutical
7.3.1 Sinopharm Guorui Pharmaceutical Details
7.3.2 Sinopharm Guorui Pharmaceutical Major Business
7.3.3 Sinopharm Guorui Pharmaceutical Carbapenem Drugs Product and Services
7.3.4 Sinopharm Guorui Pharmaceutical Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Sinopharm Guorui Pharmaceutical Recent Developments/Updates
7.3.6 Sinopharm Guorui Pharmaceutical Competitive Strengths & Weaknesses
7.4 Taiwan Biotech Co., Ltd.
7.4.1 Taiwan Biotech Co., Ltd. Details
7.4.2 Taiwan Biotech Co., Ltd. Major Business
7.4.3 Taiwan Biotech Co., Ltd. Carbapenem Drugs Product and Services
7.4.4 Taiwan Biotech Co., Ltd. Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Taiwan Biotech Co., Ltd. Recent Developments/Updates
7.4.6 Taiwan Biotech Co., Ltd. Competitive Strengths & Weaknesses
7.5 Merck
7.5.1 Merck Details
7.5.2 Merck Major Business
7.5.3 Merck Carbapenem Drugs Product and Services
7.5.4 Merck Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Merck Recent Developments/Updates
7.5.6 Merck Competitive Strengths & Weaknesses
7.6 Sun Pharmaceutical Industries Ltd.
7.6.1 Sun Pharmaceutical Industries Ltd. Details
7.6.2 Sun Pharmaceutical Industries Ltd. Major Business
7.6.3 Sun Pharmaceutical Industries Ltd. Carbapenem Drugs Product and Services
7.6.4 Sun Pharmaceutical Industries Ltd. Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
7.6.6 Sun Pharmaceutical Industries Ltd. Competitive Strengths & Weaknesses
7.7 JW Pharmaceutical
7.7.1 JW Pharmaceutical Details
7.7.2 JW Pharmaceutical Major Business
7.7.3 JW Pharmaceutical Carbapenem Drugs Product and Services
7.7.4 JW Pharmaceutical Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 JW Pharmaceutical Recent Developments/Updates
7.7.6 JW Pharmaceutical Competitive Strengths & Weaknesses
7.8 Zhengde Pharmaceutical
7.8.1 Zhengde Pharmaceutical Details
7.8.2 Zhengde Pharmaceutical Major Business
7.8.3 Zhengde Pharmaceutical Carbapenem Drugs Product and Services
7.8.4 Zhengde Pharmaceutical Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Zhengde Pharmaceutical Recent Developments/Updates
7.8.6 Zhengde Pharmaceutical Competitive Strengths & Weaknesses
7.9 Hospira Inc.
7.9.1 Hospira Inc. Details
7.9.2 Hospira Inc. Major Business
7.9.3 Hospira Inc. Carbapenem Drugs Product and Services
7.9.4 Hospira Inc. Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 Hospira Inc. Recent Developments/Updates
7.9.6 Hospira Inc. Competitive Strengths & Weaknesses
7.10 WG Critical Care
7.10.1 WG Critical Care Details
7.10.2 WG Critical Care Major Business
7.10.3 WG Critical Care Carbapenem Drugs Product and Services
7.10.4 WG Critical Care Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 WG Critical Care Recent Developments/Updates
7.10.6 WG Critical Care Competitive Strengths & Weaknesses
7.11 Hanhui Pharmaceutical
7.11.1 Hanhui Pharmaceutical Details
7.11.2 Hanhui Pharmaceutical Major Business
7.11.3 Hanhui Pharmaceutical Carbapenem Drugs Product and Services
7.11.4 Hanhui Pharmaceutical Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.11.5 Hanhui Pharmaceutical Recent Developments/Updates
7.11.6 Hanhui Pharmaceutical Competitive Strengths & Weaknesses
7.12 Zhuhai United Laboratories
7.12.1 Zhuhai United Laboratories Details
7.12.2 Zhuhai United Laboratories Major Business
7.12.3 Zhuhai United Laboratories Carbapenem Drugs Product and Services
7.12.4 Zhuhai United Laboratories Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.12.5 Zhuhai United Laboratories Recent Developments/Updates
7.12.6 Zhuhai United Laboratories Competitive Strengths & Weaknesses
7.13 ACS Dobfar S.p.A
7.13.1 ACS Dobfar S.p.A Details
7.13.2 ACS Dobfar S.p.A Major Business
7.13.3 ACS Dobfar S.p.A Carbapenem Drugs Product and Services
7.13.4 ACS Dobfar S.p.A Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.13.5 ACS Dobfar S.p.A Recent Developments/Updates
7.13.6 ACS Dobfar S.p.A Competitive Strengths & Weaknesses
7.14 Iterum Therapeutics plc (ITRM)
7.14.1 Iterum Therapeutics plc (ITRM) Details
7.14.2 Iterum Therapeutics plc (ITRM) Major Business
7.14.3 Iterum Therapeutics plc (ITRM) Carbapenem Drugs Product and Services
7.14.4 Iterum Therapeutics plc (ITRM) Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.14.5 Iterum Therapeutics plc (ITRM) Recent Developments/Updates
7.14.6 Iterum Therapeutics plc (ITRM) Competitive Strengths & Weaknesses
7.15 Daewoong Pharmaceutical
7.15.1 Daewoong Pharmaceutical Details
7.15.2 Daewoong Pharmaceutical Major Business
7.15.3 Daewoong Pharmaceutical Carbapenem Drugs Product and Services
7.15.4 Daewoong Pharmaceutical Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.15.5 Daewoong Pharmaceutical Recent Developments/Updates
7.15.6 Daewoong Pharmaceutical Competitive Strengths & Weaknesses
7.16 Aurobindo Pharma Ltd
7.16.1 Aurobindo Pharma Ltd Details
7.16.2 Aurobindo Pharma Ltd Major Business
7.16.3 Aurobindo Pharma Ltd Carbapenem Drugs Product and Services
7.16.4 Aurobindo Pharma Ltd Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.16.5 Aurobindo Pharma Ltd Recent Developments/Updates
7.16.6 Aurobindo Pharma Ltd Competitive Strengths & Weaknesses
7.17 Sumitomo Pharma
7.17.1 Sumitomo Pharma Details
7.17.2 Sumitomo Pharma Major Business
7.17.3 Sumitomo Pharma Carbapenem Drugs Product and Services
7.17.4 Sumitomo Pharma Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.17.5 Sumitomo Pharma Recent Developments/Updates
7.17.6 Sumitomo Pharma Competitive Strengths & Weaknesses
7.18 Pfizer Inc.
7.18.1 Pfizer Inc. Details
7.18.2 Pfizer Inc. Major Business
7.18.3 Pfizer Inc. Carbapenem Drugs Product and Services
7.18.4 Pfizer Inc. Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.18.5 Pfizer Inc. Recent Developments/Updates
7.18.6 Pfizer Inc. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Carbapenem Drugs Industry Chain
8.2 Carbapenem Drugs Upstream Analysis
8.2.1 Carbapenem Drugs Core Raw Materials
8.2.2 Main Manufacturers of Carbapenem Drugs Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Carbapenem Drugs Production Mode
8.6 Carbapenem Drugs Procurement Model
8.7 Carbapenem Drugs Industry Sales Model and Sales Channels
8.7.1 Carbapenem Drugs Sales Model
8.7.2 Carbapenem Drugs Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Carbapenem Drugs Introduction
1.2 World Carbapenem Drugs Supply & Forecast
1.2.1 World Carbapenem Drugs Production Value (2019 & 2023 & 2030)
1.2.2 World Carbapenem Drugs Production (2019-2030)
1.2.3 World Carbapenem Drugs Pricing Trends (2019-2030)
1.3 World Carbapenem Drugs Production by Region (Based on Production Site)
1.3.1 World Carbapenem Drugs Production Value by Region (2019-2030)
1.3.2 World Carbapenem Drugs Production by Region (2019-2030)
1.3.3 World Carbapenem Drugs Average Price by Region (2019-2030)
1.3.4 North America Carbapenem Drugs Production (2019-2030)
1.3.5 Europe Carbapenem Drugs Production (2019-2030)
1.3.6 China Carbapenem Drugs Production (2019-2030)
1.3.7 Japan Carbapenem Drugs Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Carbapenem Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Carbapenem Drugs Major Market Trends
2 DEMAND SUMMARY
2.1 World Carbapenem Drugs Demand (2019-2030)
2.2 World Carbapenem Drugs Consumption by Region
2.2.1 World Carbapenem Drugs Consumption by Region (2019-2024)
2.2.2 World Carbapenem Drugs Consumption Forecast by Region (2025-2030)
2.3 United States Carbapenem Drugs Consumption (2019-2030)
2.4 China Carbapenem Drugs Consumption (2019-2030)
2.5 Europe Carbapenem Drugs Consumption (2019-2030)
2.6 Japan Carbapenem Drugs Consumption (2019-2030)
2.7 South Korea Carbapenem Drugs Consumption (2019-2030)
2.8 ASEAN Carbapenem Drugs Consumption (2019-2030)
2.9 India Carbapenem Drugs Consumption (2019-2030)
3 WORLD CARBAPENEM DRUGS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Carbapenem Drugs Production Value by Manufacturer (2019-2024)
3.2 World Carbapenem Drugs Production by Manufacturer (2019-2024)
3.3 World Carbapenem Drugs Average Price by Manufacturer (2019-2024)
3.4 Carbapenem Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Carbapenem Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Carbapenem Drugs in 2023
3.5.3 Global Concentration Ratios (CR8) for Carbapenem Drugs in 2023
3.6 Carbapenem Drugs Market: Overall Company Footprint Analysis
3.6.1 Carbapenem Drugs Market: Region Footprint
3.6.2 Carbapenem Drugs Market: Company Product Type Footprint
3.6.3 Carbapenem Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Carbapenem Drugs Production Value Comparison
4.1.1 United States VS China: Carbapenem Drugs Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Carbapenem Drugs Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Carbapenem Drugs Production Comparison
4.2.1 United States VS China: Carbapenem Drugs Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Carbapenem Drugs Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Carbapenem Drugs Consumption Comparison
4.3.1 United States VS China: Carbapenem Drugs Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Carbapenem Drugs Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Carbapenem Drugs Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Carbapenem Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Carbapenem Drugs Production Value (2019-2024)
4.4.3 United States Based Manufacturers Carbapenem Drugs Production (2019-2024)
4.5 China Based Carbapenem Drugs Manufacturers and Market Share
4.5.1 China Based Carbapenem Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Carbapenem Drugs Production Value (2019-2024)
4.5.3 China Based Manufacturers Carbapenem Drugs Production (2019-2024)
4.6 Rest of World Based Carbapenem Drugs Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Carbapenem Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Carbapenem Drugs Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Carbapenem Drugs Production (2019-2024)
5 MARKET ANALYSIS BY TYPE
5.1 World Carbapenem Drugs Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Doripenem
5.2.2 Ertapenem
5.2.3 Imipenem
5.2.4 Meropenem
5.2.5 Panipenem
5.2.6 Biapenem
5.3 Market Segment by Type
5.3.1 World Carbapenem Drugs Production by Type (2019-2030)
5.3.2 World Carbapenem Drugs Production Value by Type (2019-2030)
5.3.3 World Carbapenem Drugs Average Price by Type (2019-2030)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Carbapenem Drugs Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Carbapenem Drugs Production by Application (2019-2030)
6.3.2 World Carbapenem Drugs Production Value by Application (2019-2030)
6.3.3 World Carbapenem Drugs Average Price by Application (2019-2030)
7 COMPANY PROFILES
7.1 Shandong New Era Pharmaceutical
7.1.1 Shandong New Era Pharmaceutical Details
7.1.2 Shandong New Era Pharmaceutical Major Business
7.1.3 Shandong New Era Pharmaceutical Carbapenem Drugs Product and Services
7.1.4 Shandong New Era Pharmaceutical Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Shandong New Era Pharmaceutical Recent Developments/Updates
7.1.6 Shandong New Era Pharmaceutical Competitive Strengths & Weaknesses
7.2 Shenzhen Haibin Pharmaceutical
7.2.1 Shenzhen Haibin Pharmaceutical Details
7.2.2 Shenzhen Haibin Pharmaceutical Major Business
7.2.3 Shenzhen Haibin Pharmaceutical Carbapenem Drugs Product and Services
7.2.4 Shenzhen Haibin Pharmaceutical Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Shenzhen Haibin Pharmaceutical Recent Developments/Updates
7.2.6 Shenzhen Haibin Pharmaceutical Competitive Strengths & Weaknesses
7.3 Sinopharm Guorui Pharmaceutical
7.3.1 Sinopharm Guorui Pharmaceutical Details
7.3.2 Sinopharm Guorui Pharmaceutical Major Business
7.3.3 Sinopharm Guorui Pharmaceutical Carbapenem Drugs Product and Services
7.3.4 Sinopharm Guorui Pharmaceutical Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Sinopharm Guorui Pharmaceutical Recent Developments/Updates
7.3.6 Sinopharm Guorui Pharmaceutical Competitive Strengths & Weaknesses
7.4 Taiwan Biotech Co., Ltd.
7.4.1 Taiwan Biotech Co., Ltd. Details
7.4.2 Taiwan Biotech Co., Ltd. Major Business
7.4.3 Taiwan Biotech Co., Ltd. Carbapenem Drugs Product and Services
7.4.4 Taiwan Biotech Co., Ltd. Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Taiwan Biotech Co., Ltd. Recent Developments/Updates
7.4.6 Taiwan Biotech Co., Ltd. Competitive Strengths & Weaknesses
7.5 Merck
7.5.1 Merck Details
7.5.2 Merck Major Business
7.5.3 Merck Carbapenem Drugs Product and Services
7.5.4 Merck Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Merck Recent Developments/Updates
7.5.6 Merck Competitive Strengths & Weaknesses
7.6 Sun Pharmaceutical Industries Ltd.
7.6.1 Sun Pharmaceutical Industries Ltd. Details
7.6.2 Sun Pharmaceutical Industries Ltd. Major Business
7.6.3 Sun Pharmaceutical Industries Ltd. Carbapenem Drugs Product and Services
7.6.4 Sun Pharmaceutical Industries Ltd. Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
7.6.6 Sun Pharmaceutical Industries Ltd. Competitive Strengths & Weaknesses
7.7 JW Pharmaceutical
7.7.1 JW Pharmaceutical Details
7.7.2 JW Pharmaceutical Major Business
7.7.3 JW Pharmaceutical Carbapenem Drugs Product and Services
7.7.4 JW Pharmaceutical Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 JW Pharmaceutical Recent Developments/Updates
7.7.6 JW Pharmaceutical Competitive Strengths & Weaknesses
7.8 Zhengde Pharmaceutical
7.8.1 Zhengde Pharmaceutical Details
7.8.2 Zhengde Pharmaceutical Major Business
7.8.3 Zhengde Pharmaceutical Carbapenem Drugs Product and Services
7.8.4 Zhengde Pharmaceutical Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Zhengde Pharmaceutical Recent Developments/Updates
7.8.6 Zhengde Pharmaceutical Competitive Strengths & Weaknesses
7.9 Hospira Inc.
7.9.1 Hospira Inc. Details
7.9.2 Hospira Inc. Major Business
7.9.3 Hospira Inc. Carbapenem Drugs Product and Services
7.9.4 Hospira Inc. Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 Hospira Inc. Recent Developments/Updates
7.9.6 Hospira Inc. Competitive Strengths & Weaknesses
7.10 WG Critical Care
7.10.1 WG Critical Care Details
7.10.2 WG Critical Care Major Business
7.10.3 WG Critical Care Carbapenem Drugs Product and Services
7.10.4 WG Critical Care Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 WG Critical Care Recent Developments/Updates
7.10.6 WG Critical Care Competitive Strengths & Weaknesses
7.11 Hanhui Pharmaceutical
7.11.1 Hanhui Pharmaceutical Details
7.11.2 Hanhui Pharmaceutical Major Business
7.11.3 Hanhui Pharmaceutical Carbapenem Drugs Product and Services
7.11.4 Hanhui Pharmaceutical Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.11.5 Hanhui Pharmaceutical Recent Developments/Updates
7.11.6 Hanhui Pharmaceutical Competitive Strengths & Weaknesses
7.12 Zhuhai United Laboratories
7.12.1 Zhuhai United Laboratories Details
7.12.2 Zhuhai United Laboratories Major Business
7.12.3 Zhuhai United Laboratories Carbapenem Drugs Product and Services
7.12.4 Zhuhai United Laboratories Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.12.5 Zhuhai United Laboratories Recent Developments/Updates
7.12.6 Zhuhai United Laboratories Competitive Strengths & Weaknesses
7.13 ACS Dobfar S.p.A
7.13.1 ACS Dobfar S.p.A Details
7.13.2 ACS Dobfar S.p.A Major Business
7.13.3 ACS Dobfar S.p.A Carbapenem Drugs Product and Services
7.13.4 ACS Dobfar S.p.A Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.13.5 ACS Dobfar S.p.A Recent Developments/Updates
7.13.6 ACS Dobfar S.p.A Competitive Strengths & Weaknesses
7.14 Iterum Therapeutics plc (ITRM)
7.14.1 Iterum Therapeutics plc (ITRM) Details
7.14.2 Iterum Therapeutics plc (ITRM) Major Business
7.14.3 Iterum Therapeutics plc (ITRM) Carbapenem Drugs Product and Services
7.14.4 Iterum Therapeutics plc (ITRM) Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.14.5 Iterum Therapeutics plc (ITRM) Recent Developments/Updates
7.14.6 Iterum Therapeutics plc (ITRM) Competitive Strengths & Weaknesses
7.15 Daewoong Pharmaceutical
7.15.1 Daewoong Pharmaceutical Details
7.15.2 Daewoong Pharmaceutical Major Business
7.15.3 Daewoong Pharmaceutical Carbapenem Drugs Product and Services
7.15.4 Daewoong Pharmaceutical Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.15.5 Daewoong Pharmaceutical Recent Developments/Updates
7.15.6 Daewoong Pharmaceutical Competitive Strengths & Weaknesses
7.16 Aurobindo Pharma Ltd
7.16.1 Aurobindo Pharma Ltd Details
7.16.2 Aurobindo Pharma Ltd Major Business
7.16.3 Aurobindo Pharma Ltd Carbapenem Drugs Product and Services
7.16.4 Aurobindo Pharma Ltd Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.16.5 Aurobindo Pharma Ltd Recent Developments/Updates
7.16.6 Aurobindo Pharma Ltd Competitive Strengths & Weaknesses
7.17 Sumitomo Pharma
7.17.1 Sumitomo Pharma Details
7.17.2 Sumitomo Pharma Major Business
7.17.3 Sumitomo Pharma Carbapenem Drugs Product and Services
7.17.4 Sumitomo Pharma Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.17.5 Sumitomo Pharma Recent Developments/Updates
7.17.6 Sumitomo Pharma Competitive Strengths & Weaknesses
7.18 Pfizer Inc.
7.18.1 Pfizer Inc. Details
7.18.2 Pfizer Inc. Major Business
7.18.3 Pfizer Inc. Carbapenem Drugs Product and Services
7.18.4 Pfizer Inc. Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.18.5 Pfizer Inc. Recent Developments/Updates
7.18.6 Pfizer Inc. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Carbapenem Drugs Industry Chain
8.2 Carbapenem Drugs Upstream Analysis
8.2.1 Carbapenem Drugs Core Raw Materials
8.2.2 Main Manufacturers of Carbapenem Drugs Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Carbapenem Drugs Production Mode
8.6 Carbapenem Drugs Procurement Model
8.7 Carbapenem Drugs Industry Sales Model and Sales Channels
8.7.1 Carbapenem Drugs Sales Model
8.7.2 Carbapenem Drugs Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Carbapenem Drugs Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Carbapenem Drugs Production Value by Region (2019-2024) & (USD Million)
Table 3. World Carbapenem Drugs Production Value by Region (2025-2030) & (USD Million)
Table 4. World Carbapenem Drugs Production Value Market Share by Region (2019-2024)
Table 5. World Carbapenem Drugs Production Value Market Share by Region (2025-2030)
Table 6. World Carbapenem Drugs Production by Region (2019-2024) & (K Units)
Table 7. World Carbapenem Drugs Production by Region (2025-2030) & (K Units)
Table 8. World Carbapenem Drugs Production Market Share by Region (2019-2024)
Table 9. World Carbapenem Drugs Production Market Share by Region (2025-2030)
Table 10. World Carbapenem Drugs Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Carbapenem Drugs Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Carbapenem Drugs Major Market Trends
Table 13. World Carbapenem Drugs Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Carbapenem Drugs Consumption by Region (2019-2024) & (K Units)
Table 15. World Carbapenem Drugs Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Carbapenem Drugs Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Carbapenem Drugs Producers in 2023
Table 18. World Carbapenem Drugs Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Carbapenem Drugs Producers in 2023
Table 20. World Carbapenem Drugs Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Carbapenem Drugs Company Evaluation Quadrant
Table 22. World Carbapenem Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Carbapenem Drugs Production Site of Key Manufacturer
Table 24. Carbapenem Drugs Market: Company Product Type Footprint
Table 25. Carbapenem Drugs Market: Company Product Application Footprint
Table 26. Carbapenem Drugs Competitive Factors
Table 27. Carbapenem Drugs New Entrant and Capacity Expansion Plans
Table 28. Carbapenem Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Carbapenem Drugs Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Carbapenem Drugs Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Carbapenem Drugs Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Carbapenem Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Carbapenem Drugs Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Carbapenem Drugs Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Carbapenem Drugs Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Carbapenem Drugs Production Market Share (2019-2024)
Table 37. China Based Carbapenem Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Carbapenem Drugs Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Carbapenem Drugs Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Carbapenem Drugs Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Carbapenem Drugs Production Market Share (2019-2024)
Table 42. Rest of World Based Carbapenem Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Carbapenem Drugs Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Carbapenem Drugs Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Carbapenem Drugs Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Carbapenem Drugs Production Market Share (2019-2024)
Table 47. World Carbapenem Drugs Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Carbapenem Drugs Production by Type (2019-2024) & (K Units)
Table 49. World Carbapenem Drugs Production by Type (2025-2030) & (K Units)
Table 50. World Carbapenem Drugs Production Value by Type (2019-2024) & (USD Million)
Table 51. World Carbapenem Drugs Production Value by Type (2025-2030) & (USD Million)
Table 52. World Carbapenem Drugs Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Carbapenem Drugs Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Carbapenem Drugs Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Carbapenem Drugs Production by Application (2019-2024) & (K Units)
Table 56. World Carbapenem Drugs Production by Application (2025-2030) & (K Units)
Table 57. World Carbapenem Drugs Production Value by Application (2019-2024) & (USD Million)
Table 58. World Carbapenem Drugs Production Value by Application (2025-2030) & (USD Million)
Table 59. World Carbapenem Drugs Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Carbapenem Drugs Average Price by Application (2025-2030) & (US$/Unit)
Table 61. Shandong New Era Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 62. Shandong New Era Pharmaceutical Major Business
Table 63. Shandong New Era Pharmaceutical Carbapenem Drugs Product and Services
Table 64. Shandong New Era Pharmaceutical Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Shandong New Era Pharmaceutical Recent Developments/Updates
Table 66. Shandong New Era Pharmaceutical Competitive Strengths & Weaknesses
Table 67. Shenzhen Haibin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 68. Shenzhen Haibin Pharmaceutical Major Business
Table 69. Shenzhen Haibin Pharmaceutical Carbapenem Drugs Product and Services
Table 70. Shenzhen Haibin Pharmaceutical Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Shenzhen Haibin Pharmaceutical Recent Developments/Updates
Table 72. Shenzhen Haibin Pharmaceutical Competitive Strengths & Weaknesses
Table 73. Sinopharm Guorui Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 74. Sinopharm Guorui Pharmaceutical Major Business
Table 75. Sinopharm Guorui Pharmaceutical Carbapenem Drugs Product and Services
Table 76. Sinopharm Guorui Pharmaceutical Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Sinopharm Guorui Pharmaceutical Recent Developments/Updates
Table 78. Sinopharm Guorui Pharmaceutical Competitive Strengths & Weaknesses
Table 79. Taiwan Biotech Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 80. Taiwan Biotech Co., Ltd. Major Business
Table 81. Taiwan Biotech Co., Ltd. Carbapenem Drugs Product and Services
Table 82. Taiwan Biotech Co., Ltd. Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Taiwan Biotech Co., Ltd. Recent Developments/Updates
Table 84. Taiwan Biotech Co., Ltd. Competitive Strengths & Weaknesses
Table 85. Merck Basic Information, Manufacturing Base and Competitors
Table 86. Merck Major Business
Table 87. Merck Carbapenem Drugs Product and Services
Table 88. Merck Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Merck Recent Developments/Updates
Table 90. Merck Competitive Strengths & Weaknesses
Table 91. Sun Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 92. Sun Pharmaceutical Industries Ltd. Major Business
Table 93. Sun Pharmaceutical Industries Ltd. Carbapenem Drugs Product and Services
Table 94. Sun Pharmaceutical Industries Ltd. Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 96. Sun Pharmaceutical Industries Ltd. Competitive Strengths & Weaknesses
Table 97. JW Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 98. JW Pharmaceutical Major Business
Table 99. JW Pharmaceutical Carbapenem Drugs Product and Services
Table 100. JW Pharmaceutical Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. JW Pharmaceutical Recent Developments/Updates
Table 102. JW Pharmaceutical Competitive Strengths & Weaknesses
Table 103. Zhengde Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 104. Zhengde Pharmaceutical Major Business
Table 105. Zhengde Pharmaceutical Carbapenem Drugs Product and Services
Table 106. Zhengde Pharmaceutical Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Zhengde Pharmaceutical Recent Developments/Updates
Table 108. Zhengde Pharmaceutical Competitive Strengths & Weaknesses
Table 109. Hospira Inc. Basic Information, Manufacturing Base and Competitors
Table 110. Hospira Inc. Major Business
Table 111. Hospira Inc. Carbapenem Drugs Product and Services
Table 112. Hospira Inc. Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. Hospira Inc. Recent Developments/Updates
Table 114. Hospira Inc. Competitive Strengths & Weaknesses
Table 115. WG Critical Care Basic Information, Manufacturing Base and Competitors
Table 116. WG Critical Care Major Business
Table 117. WG Critical Care Carbapenem Drugs Product and Services
Table 118. WG Critical Care Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. WG Critical Care Recent Developments/Updates
Table 120. WG Critical Care Competitive Strengths & Weaknesses
Table 121. Hanhui Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 122. Hanhui Pharmaceutical Major Business
Table 123. Hanhui Pharmaceutical Carbapenem Drugs Product and Services
Table 124. Hanhui Pharmaceutical Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 125. Hanhui Pharmaceutical Recent Developments/Updates
Table 126. Hanhui Pharmaceutical Competitive Strengths & Weaknesses
Table 127. Zhuhai United Laboratories Basic Information, Manufacturing Base and Competitors
Table 128. Zhuhai United Laboratories Major Business
Table 129. Zhuhai United Laboratories Carbapenem Drugs Product and Services
Table 130. Zhuhai United Laboratories Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 131. Zhuhai United Laboratories Recent Developments/Updates
Table 132. Zhuhai United Laboratories Competitive Strengths & Weaknesses
Table 133. ACS Dobfar S.p.A Basic Information, Manufacturing Base and Competitors
Table 134. ACS Dobfar S.p.A Major Business
Table 135. ACS Dobfar S.p.A Carbapenem Drugs Product and Services
Table 136. ACS Dobfar S.p.A Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 137. ACS Dobfar S.p.A Recent Developments/Updates
Table 138. ACS Dobfar S.p.A Competitive Strengths & Weaknesses
Table 139. Iterum Therapeutics plc (ITRM) Basic Information, Manufacturing Base and Competitors
Table 140. Iterum Therapeutics plc (ITRM) Major Business
Table 141. Iterum Therapeutics plc (ITRM) Carbapenem Drugs Product and Services
Table 142. Iterum Therapeutics plc (ITRM) Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 143. Iterum Therapeutics plc (ITRM) Recent Developments/Updates
Table 144. Iterum Therapeutics plc (ITRM) Competitive Strengths & Weaknesses
Table 145. Daewoong Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 146. Daewoong Pharmaceutical Major Business
Table 147. Daewoong Pharmaceutical Carbapenem Drugs Product and Services
Table 148. Daewoong Pharmaceutical Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 149. Daewoong Pharmaceutical Recent Developments/Updates
Table 150. Daewoong Pharmaceutical Competitive Strengths & Weaknesses
Table 151. Aurobindo Pharma Ltd Basic Information, Manufacturing Base and Competitors
Table 152. Aurobindo Pharma Ltd Major Business
Table 153. Aurobindo Pharma Ltd Carbapenem Drugs Product and Services
Table 154. Aurobindo Pharma Ltd Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 155. Aurobindo Pharma Ltd Recent Developments/Updates
Table 156. Aurobindo Pharma Ltd Competitive Strengths & Weaknesses
Table 157. Sumitomo Pharma Basic Information, Manufacturing Base and Competitors
Table 158. Sumitomo Pharma Major Business
Table 159. Sumitomo Pharma Carbapenem Drugs Product and Services
Table 160. Sumitomo Pharma Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 161. Sumitomo Pharma Recent Developments/Updates
Table 162. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 163. Pfizer Inc. Major Business
Table 164. Pfizer Inc. Carbapenem Drugs Product and Services
Table 165. Pfizer Inc. Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 166. Global Key Players of Carbapenem Drugs Upstream (Raw Materials)
Table 167. Carbapenem Drugs Typical Customers
Table 168. Carbapenem Drugs Typical Distributors
LIST OF FIGURE
Figure 1. Carbapenem Drugs Picture
Figure 2. World Carbapenem Drugs Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Carbapenem Drugs Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Carbapenem Drugs Production (2019-2030) & (K Units)
Figure 5. World Carbapenem Drugs Average Price (2019-2030) & (US$/Unit)
Figure 6. World Carbapenem Drugs Production Value Market Share by Region (2019-2030)
Figure 7. World Carbapenem Drugs Production Market Share by Region (2019-2030)
Figure 8. North America Carbapenem Drugs Production (2019-2030) & (K Units)
Figure 9. Europe Carbapenem Drugs Production (2019-2030) & (K Units)
Figure 10. China Carbapenem Drugs Production (2019-2030) & (K Units)
Figure 11. Japan Carbapenem Drugs Production (2019-2030) & (K Units)
Figure 12. Carbapenem Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Carbapenem Drugs Consumption (2019-2030) & (K Units)
Figure 15. World Carbapenem Drugs Consumption Market Share by Region (2019-2030)
Figure 16. United States Carbapenem Drugs Consumption (2019-2030) & (K Units)
Figure 17. China Carbapenem Drugs Consumption (2019-2030) & (K Units)
Figure 18. Europe Carbapenem Drugs Consumption (2019-2030) & (K Units)
Figure 19. Japan Carbapenem Drugs Consumption (2019-2030) & (K Units)
Figure 20. South Korea Carbapenem Drugs Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Carbapenem Drugs Consumption (2019-2030) & (K Units)
Figure 22. India Carbapenem Drugs Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Carbapenem Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Carbapenem Drugs Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Carbapenem Drugs Markets in 2023
Figure 26. United States VS China: Carbapenem Drugs Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Carbapenem Drugs Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Carbapenem Drugs Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Carbapenem Drugs Production Market Share 2023
Figure 30. China Based Manufacturers Carbapenem Drugs Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Carbapenem Drugs Production Market Share 2023
Figure 32. World Carbapenem Drugs Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Carbapenem Drugs Production Value Market Share by Type in 2023
Figure 34. Doripenem
Figure 35. Ertapenem
Figure 36. Imipenem
Figure 37. Meropenem
Figure 38. Panipenem
Figure 39. Biapenem
Figure 40. World Carbapenem Drugs Production Market Share by Type (2019-2030)
Figure 41. World Carbapenem Drugs Production Value Market Share by Type (2019-2030)
Figure 42. World Carbapenem Drugs Average Price by Type (2019-2030) & (US$/Unit)
Figure 43. World Carbapenem Drugs Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 44. World Carbapenem Drugs Production Value Market Share by Application in 2023
Figure 45. Hospital
Figure 46. Clinic
Figure 47. Others
Figure 48. World Carbapenem Drugs Production Market Share by Application (2019-2030)
Figure 49. World Carbapenem Drugs Production Value Market Share by Application (2019-2030)
Figure 50. World Carbapenem Drugs Average Price by Application (2019-2030) & (US$/Unit)
Figure 51. Carbapenem Drugs Industry Chain
Figure 52. Carbapenem Drugs Procurement Model
Figure 53. Carbapenem Drugs Sales Model
Figure 54. Carbapenem Drugs Sales Channels, Direct Sales, and Distribution
Figure 55. Methodology
Figure 56. Research Process and Data Source
Table 1. World Carbapenem Drugs Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Carbapenem Drugs Production Value by Region (2019-2024) & (USD Million)
Table 3. World Carbapenem Drugs Production Value by Region (2025-2030) & (USD Million)
Table 4. World Carbapenem Drugs Production Value Market Share by Region (2019-2024)
Table 5. World Carbapenem Drugs Production Value Market Share by Region (2025-2030)
Table 6. World Carbapenem Drugs Production by Region (2019-2024) & (K Units)
Table 7. World Carbapenem Drugs Production by Region (2025-2030) & (K Units)
Table 8. World Carbapenem Drugs Production Market Share by Region (2019-2024)
Table 9. World Carbapenem Drugs Production Market Share by Region (2025-2030)
Table 10. World Carbapenem Drugs Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Carbapenem Drugs Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Carbapenem Drugs Major Market Trends
Table 13. World Carbapenem Drugs Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Carbapenem Drugs Consumption by Region (2019-2024) & (K Units)
Table 15. World Carbapenem Drugs Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Carbapenem Drugs Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Carbapenem Drugs Producers in 2023
Table 18. World Carbapenem Drugs Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Carbapenem Drugs Producers in 2023
Table 20. World Carbapenem Drugs Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Carbapenem Drugs Company Evaluation Quadrant
Table 22. World Carbapenem Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Carbapenem Drugs Production Site of Key Manufacturer
Table 24. Carbapenem Drugs Market: Company Product Type Footprint
Table 25. Carbapenem Drugs Market: Company Product Application Footprint
Table 26. Carbapenem Drugs Competitive Factors
Table 27. Carbapenem Drugs New Entrant and Capacity Expansion Plans
Table 28. Carbapenem Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Carbapenem Drugs Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Carbapenem Drugs Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Carbapenem Drugs Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Carbapenem Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Carbapenem Drugs Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Carbapenem Drugs Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Carbapenem Drugs Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Carbapenem Drugs Production Market Share (2019-2024)
Table 37. China Based Carbapenem Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Carbapenem Drugs Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Carbapenem Drugs Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Carbapenem Drugs Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Carbapenem Drugs Production Market Share (2019-2024)
Table 42. Rest of World Based Carbapenem Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Carbapenem Drugs Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Carbapenem Drugs Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Carbapenem Drugs Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Carbapenem Drugs Production Market Share (2019-2024)
Table 47. World Carbapenem Drugs Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Carbapenem Drugs Production by Type (2019-2024) & (K Units)
Table 49. World Carbapenem Drugs Production by Type (2025-2030) & (K Units)
Table 50. World Carbapenem Drugs Production Value by Type (2019-2024) & (USD Million)
Table 51. World Carbapenem Drugs Production Value by Type (2025-2030) & (USD Million)
Table 52. World Carbapenem Drugs Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Carbapenem Drugs Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Carbapenem Drugs Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Carbapenem Drugs Production by Application (2019-2024) & (K Units)
Table 56. World Carbapenem Drugs Production by Application (2025-2030) & (K Units)
Table 57. World Carbapenem Drugs Production Value by Application (2019-2024) & (USD Million)
Table 58. World Carbapenem Drugs Production Value by Application (2025-2030) & (USD Million)
Table 59. World Carbapenem Drugs Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Carbapenem Drugs Average Price by Application (2025-2030) & (US$/Unit)
Table 61. Shandong New Era Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 62. Shandong New Era Pharmaceutical Major Business
Table 63. Shandong New Era Pharmaceutical Carbapenem Drugs Product and Services
Table 64. Shandong New Era Pharmaceutical Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Shandong New Era Pharmaceutical Recent Developments/Updates
Table 66. Shandong New Era Pharmaceutical Competitive Strengths & Weaknesses
Table 67. Shenzhen Haibin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 68. Shenzhen Haibin Pharmaceutical Major Business
Table 69. Shenzhen Haibin Pharmaceutical Carbapenem Drugs Product and Services
Table 70. Shenzhen Haibin Pharmaceutical Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Shenzhen Haibin Pharmaceutical Recent Developments/Updates
Table 72. Shenzhen Haibin Pharmaceutical Competitive Strengths & Weaknesses
Table 73. Sinopharm Guorui Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 74. Sinopharm Guorui Pharmaceutical Major Business
Table 75. Sinopharm Guorui Pharmaceutical Carbapenem Drugs Product and Services
Table 76. Sinopharm Guorui Pharmaceutical Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Sinopharm Guorui Pharmaceutical Recent Developments/Updates
Table 78. Sinopharm Guorui Pharmaceutical Competitive Strengths & Weaknesses
Table 79. Taiwan Biotech Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 80. Taiwan Biotech Co., Ltd. Major Business
Table 81. Taiwan Biotech Co., Ltd. Carbapenem Drugs Product and Services
Table 82. Taiwan Biotech Co., Ltd. Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Taiwan Biotech Co., Ltd. Recent Developments/Updates
Table 84. Taiwan Biotech Co., Ltd. Competitive Strengths & Weaknesses
Table 85. Merck Basic Information, Manufacturing Base and Competitors
Table 86. Merck Major Business
Table 87. Merck Carbapenem Drugs Product and Services
Table 88. Merck Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Merck Recent Developments/Updates
Table 90. Merck Competitive Strengths & Weaknesses
Table 91. Sun Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 92. Sun Pharmaceutical Industries Ltd. Major Business
Table 93. Sun Pharmaceutical Industries Ltd. Carbapenem Drugs Product and Services
Table 94. Sun Pharmaceutical Industries Ltd. Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 96. Sun Pharmaceutical Industries Ltd. Competitive Strengths & Weaknesses
Table 97. JW Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 98. JW Pharmaceutical Major Business
Table 99. JW Pharmaceutical Carbapenem Drugs Product and Services
Table 100. JW Pharmaceutical Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. JW Pharmaceutical Recent Developments/Updates
Table 102. JW Pharmaceutical Competitive Strengths & Weaknesses
Table 103. Zhengde Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 104. Zhengde Pharmaceutical Major Business
Table 105. Zhengde Pharmaceutical Carbapenem Drugs Product and Services
Table 106. Zhengde Pharmaceutical Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Zhengde Pharmaceutical Recent Developments/Updates
Table 108. Zhengde Pharmaceutical Competitive Strengths & Weaknesses
Table 109. Hospira Inc. Basic Information, Manufacturing Base and Competitors
Table 110. Hospira Inc. Major Business
Table 111. Hospira Inc. Carbapenem Drugs Product and Services
Table 112. Hospira Inc. Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. Hospira Inc. Recent Developments/Updates
Table 114. Hospira Inc. Competitive Strengths & Weaknesses
Table 115. WG Critical Care Basic Information, Manufacturing Base and Competitors
Table 116. WG Critical Care Major Business
Table 117. WG Critical Care Carbapenem Drugs Product and Services
Table 118. WG Critical Care Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. WG Critical Care Recent Developments/Updates
Table 120. WG Critical Care Competitive Strengths & Weaknesses
Table 121. Hanhui Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 122. Hanhui Pharmaceutical Major Business
Table 123. Hanhui Pharmaceutical Carbapenem Drugs Product and Services
Table 124. Hanhui Pharmaceutical Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 125. Hanhui Pharmaceutical Recent Developments/Updates
Table 126. Hanhui Pharmaceutical Competitive Strengths & Weaknesses
Table 127. Zhuhai United Laboratories Basic Information, Manufacturing Base and Competitors
Table 128. Zhuhai United Laboratories Major Business
Table 129. Zhuhai United Laboratories Carbapenem Drugs Product and Services
Table 130. Zhuhai United Laboratories Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 131. Zhuhai United Laboratories Recent Developments/Updates
Table 132. Zhuhai United Laboratories Competitive Strengths & Weaknesses
Table 133. ACS Dobfar S.p.A Basic Information, Manufacturing Base and Competitors
Table 134. ACS Dobfar S.p.A Major Business
Table 135. ACS Dobfar S.p.A Carbapenem Drugs Product and Services
Table 136. ACS Dobfar S.p.A Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 137. ACS Dobfar S.p.A Recent Developments/Updates
Table 138. ACS Dobfar S.p.A Competitive Strengths & Weaknesses
Table 139. Iterum Therapeutics plc (ITRM) Basic Information, Manufacturing Base and Competitors
Table 140. Iterum Therapeutics plc (ITRM) Major Business
Table 141. Iterum Therapeutics plc (ITRM) Carbapenem Drugs Product and Services
Table 142. Iterum Therapeutics plc (ITRM) Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 143. Iterum Therapeutics plc (ITRM) Recent Developments/Updates
Table 144. Iterum Therapeutics plc (ITRM) Competitive Strengths & Weaknesses
Table 145. Daewoong Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 146. Daewoong Pharmaceutical Major Business
Table 147. Daewoong Pharmaceutical Carbapenem Drugs Product and Services
Table 148. Daewoong Pharmaceutical Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 149. Daewoong Pharmaceutical Recent Developments/Updates
Table 150. Daewoong Pharmaceutical Competitive Strengths & Weaknesses
Table 151. Aurobindo Pharma Ltd Basic Information, Manufacturing Base and Competitors
Table 152. Aurobindo Pharma Ltd Major Business
Table 153. Aurobindo Pharma Ltd Carbapenem Drugs Product and Services
Table 154. Aurobindo Pharma Ltd Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 155. Aurobindo Pharma Ltd Recent Developments/Updates
Table 156. Aurobindo Pharma Ltd Competitive Strengths & Weaknesses
Table 157. Sumitomo Pharma Basic Information, Manufacturing Base and Competitors
Table 158. Sumitomo Pharma Major Business
Table 159. Sumitomo Pharma Carbapenem Drugs Product and Services
Table 160. Sumitomo Pharma Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 161. Sumitomo Pharma Recent Developments/Updates
Table 162. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 163. Pfizer Inc. Major Business
Table 164. Pfizer Inc. Carbapenem Drugs Product and Services
Table 165. Pfizer Inc. Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 166. Global Key Players of Carbapenem Drugs Upstream (Raw Materials)
Table 167. Carbapenem Drugs Typical Customers
Table 168. Carbapenem Drugs Typical Distributors
LIST OF FIGURE
Figure 1. Carbapenem Drugs Picture
Figure 2. World Carbapenem Drugs Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Carbapenem Drugs Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Carbapenem Drugs Production (2019-2030) & (K Units)
Figure 5. World Carbapenem Drugs Average Price (2019-2030) & (US$/Unit)
Figure 6. World Carbapenem Drugs Production Value Market Share by Region (2019-2030)
Figure 7. World Carbapenem Drugs Production Market Share by Region (2019-2030)
Figure 8. North America Carbapenem Drugs Production (2019-2030) & (K Units)
Figure 9. Europe Carbapenem Drugs Production (2019-2030) & (K Units)
Figure 10. China Carbapenem Drugs Production (2019-2030) & (K Units)
Figure 11. Japan Carbapenem Drugs Production (2019-2030) & (K Units)
Figure 12. Carbapenem Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Carbapenem Drugs Consumption (2019-2030) & (K Units)
Figure 15. World Carbapenem Drugs Consumption Market Share by Region (2019-2030)
Figure 16. United States Carbapenem Drugs Consumption (2019-2030) & (K Units)
Figure 17. China Carbapenem Drugs Consumption (2019-2030) & (K Units)
Figure 18. Europe Carbapenem Drugs Consumption (2019-2030) & (K Units)
Figure 19. Japan Carbapenem Drugs Consumption (2019-2030) & (K Units)
Figure 20. South Korea Carbapenem Drugs Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Carbapenem Drugs Consumption (2019-2030) & (K Units)
Figure 22. India Carbapenem Drugs Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Carbapenem Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Carbapenem Drugs Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Carbapenem Drugs Markets in 2023
Figure 26. United States VS China: Carbapenem Drugs Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Carbapenem Drugs Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Carbapenem Drugs Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Carbapenem Drugs Production Market Share 2023
Figure 30. China Based Manufacturers Carbapenem Drugs Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Carbapenem Drugs Production Market Share 2023
Figure 32. World Carbapenem Drugs Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Carbapenem Drugs Production Value Market Share by Type in 2023
Figure 34. Doripenem
Figure 35. Ertapenem
Figure 36. Imipenem
Figure 37. Meropenem
Figure 38. Panipenem
Figure 39. Biapenem
Figure 40. World Carbapenem Drugs Production Market Share by Type (2019-2030)
Figure 41. World Carbapenem Drugs Production Value Market Share by Type (2019-2030)
Figure 42. World Carbapenem Drugs Average Price by Type (2019-2030) & (US$/Unit)
Figure 43. World Carbapenem Drugs Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 44. World Carbapenem Drugs Production Value Market Share by Application in 2023
Figure 45. Hospital
Figure 46. Clinic
Figure 47. Others
Figure 48. World Carbapenem Drugs Production Market Share by Application (2019-2030)
Figure 49. World Carbapenem Drugs Production Value Market Share by Application (2019-2030)
Figure 50. World Carbapenem Drugs Average Price by Application (2019-2030) & (US$/Unit)
Figure 51. Carbapenem Drugs Industry Chain
Figure 52. Carbapenem Drugs Procurement Model
Figure 53. Carbapenem Drugs Sales Model
Figure 54. Carbapenem Drugs Sales Channels, Direct Sales, and Distribution
Figure 55. Methodology
Figure 56. Research Process and Data Source
